Welcome to eBioscience   Tel: 888.999.1371 or 858.642.2058
Fax: 858.642.2046
Web: www.ebioscience.com
E-mail: info@ebioscience.com

Product Information


Contents: Affinity Purified anti-mouse/human OCT3/4, Pou5f1, transcription factor 1
Catalog Number: 14-5841
Sizes: 25 ug, 100 ug
Formulation: Phosphate buffered saline, pH 7.2, less than or equal to 0.09% NaN3
Storage Conditions: Store at 4°C.
Avoid repeated freeze/thaw cycles.
Clone: EM92
Isotype: Rat IgG2a, κ
 
 
data image 1
F9 mouse embryonal carcinoma cell (left) and mouse spleen cell lysates were loaded at 1x105 cells/lane, probed with 2 µg/mL purified EM92 and revealed with HRP anti-rat IgG. 

Available Formats of This Product
Cat. No. Format Excite
(nm)
Emit
(nm)
Reported Applications
14-5841 Affinity Purified anti-mouse/human OCT3/4, Pou5f1, transcription factor 1 N/A N/A MIC  WB 
12-5841 Phycoerythrin (PE) anti-mouse/human OCT3/4, Pou5f1, transcription factor 1 488 575 IC Flow 
51-5841 Alexa Fluor® 647 anti-mouse/human OCT3/4, Pou5f1, transcription factor 1 633 668 IC Flow  MIC 
53-5841 Alexa Fluor® 488 anti-mouse/human OCT3/4, Pou5f1, transcription factor 1 488 519 IC Flow  MIC 
Flow Cytometry Product Notes:
Test Sizes: To accommodate multicolor flow cytometry, eBioscience is in the process of reducing test size volumes from 20 µl to 5 µl. Please check your antibody vial for the recommended test size.
Fluorochrome Replacements: eBioscience is in the process of replacing all Pacific Blue® and APC-Alexa Fluor® 750 conjugated products with eFluor™ 450 and APC-eFluor™ 780 conjugated products, respectively.

Custom Product Requests
Need a custom product? Download the Custom Product Request Form and submit completed form to customs@ebioscience.com.

Questions? Please consult our answers to frequently asked questions at http://www.ebioscience.com/faq.

Description


The EM92 monoclonal antibody reacts with mouse and human Oct-3/4, encoded by the Pou5F1 gene. Oct-3/4 is a POU domain-containing transcription factor that is critical for maintaining embryonic stem (ES) cells in a pluripotent state, and is expressed by ES, embryonic germ cells and embryonic carcinoma cell lines. In cells of the inner cell mass (ICM), reduction of Oct-3/4 expression causes dedifferentiation to trophoectoderm, whereas increased expression results in differentiation to mesoderm and primitive endoderm. Oct-3/4 regulates the expression of several genes, including FGF-4, UTF1, Sox2, Fbx15, Rex1 and osteopontin through distinct mechanisms. Furthermore, Oct-3/4 frequently acts synergistically with Sox2 to regulate target gene expression, as is the case with FGF-4. It has been demonstrated that Oct-3/4 expression in ES cells can be negatively regulated by either treatment with retinoic acid, or by removal of leukemia-inhibitory factor (LIF).


Applications Reported


For research use only, not for diagnostic or therapeutic use. This EM92 antibody has been reported for use in immunoblotting (WB).


Applications Tested


This EM92 antibody has been tested by western blot analysis of F9 and P19 embryonal carcinoma cell lysates. For western blotting, this antibody can be used at a starting dilution 2 ug\ml. However, the antibody should be titrated for individual experiments.


References


Okamoto K, Okazawa H, Okuda A, Sakai M, Muramatsu M, Hamada H. A novel octamer binding transcription factor is differentially expressed in mouse embryonic cells. Cell. 1990 Feb 9;60(3):461-72.

Pikarsky E, Sharir H, Ben-Shushan E, Bergman Y. Retinoic acid represses Oct-3/4 gene expression through several retinoic acid-responsive elements located in the promoter-enhancer region. Mol Cell Biol. 1994 Feb;14(2):1026-38.

Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007 Nov 30;131(5):861-72


Related Products


Cat. 14-4321  Affinity Purified Rat IgG2a Isotype Control



Copyright © 2000-2008 eBioscience, Inc.
For Research Use Only. Not for use in diagnostic procedures. Not for further distribution without written consent.